Udmærkelser
Det er vores forpligtelse at opdage, udvikle og levere innovative lægemidler, der hjælper patienter med at overvinde alvorlige sygdomme. De skridt vi har taget, og den kultur vi har skabt, er yderst værdsat og anerkendt.
Over årene har Bristol-Myers Squibb og virksomhedens medarbejdere modtaget adskillige fremtrædende priser og anerkendelser, herunder Great Place to Work i Danmark, the National Medal of Technology, the Lasker Award for medicinsk forskning og the Prix Galien Award.
År efter år er vi blevet hyldet som en af de bedste virksomheder for arbejdende mødre, et godt sted at være for forskere samt førende i industrien i forhold til miljø og sundhed.
Nedenstående er et udpluk af de priser og anerkendelser, vi har modtaget.
100 Best Corporate Citizens 2017

CEO Cancer Gold Standard

The CEO Roundtable on Cancer has accredited Bristol-Myers Squibb with the CEO Cancer Gold Standard™ recognizing our efforts to reduce the risk of cancer for employees and covered family members.
Dow Jones' 2016 North American Index of Leading Sustainable Companies

America’s Best Employers for 2016

2015 Society for Immunotherapy of Cancer (SITC) Collaborator Award

Great Place to Work

For us as an employer our employees experience at work is important so therefore have we choose to be part of the Great Place to Work program.
2016 Working Mother 100 Best Companies

Most Admired Company in Supplier Diversity

“Simply the Best” Award

2015 Collaborator Award

Best Places to Work across the U.S. and the U.K.

100% score on the 2017 Corporate Equality Index (CEI)

2016 NAFE Top Companies for Executive Women

World’s Most Innovative Companies for 2016 / Top 10 Most Innovative Companies in Biotech

Top 8 Pharma Companies to Work For

2015 Top 20 R&D Employer

2017 Energy Star Partner of the Year

Pharmaceutical Executive Magazine/PharmExec.com’s 2016 Brand of the Year

World’s Most Admired Companies

Top 30 Best-of-the-Best

Best Biotechnology Product

50 Smartest Companies

In June, the MIT Technology Review named Bristol-Myers Squibb to its 50 Smartest Companies list for 2015. We were ranked No. 26 and recognized as a leader in Immuno-Oncology.